Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy
- 18 December 2002
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (12) , 2165-2173
- https://doi.org/10.1016/s0735-1097(02)02595-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Matrix Metalloproteinase Inhibition After Myocardial InfarctionCirculation Research, 2001
- Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndromeAmerican Heart Journal, 2001
- Expression of Matrix Metalloproteinases in Patients With Acute Myocardial InfarctionJapanese Circulation Journal, 2001
- A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart FailureCirculation, 2000
- Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarctionJournal of Clinical Investigation, 2000
- Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failureNature Medicine, 1999
- Matrix Metalloproteinase Inhibition During the Development of Congestive Heart FailureCirculation Research, 1999
- Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in MiceCirculation, 1999
- Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human HeartCirculation, 1998
- Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated CardiomyopathyCirculation, 1998